Guardant Health, INC Form 4 insider transactions

Guardant Health's Chief Information Officer, Kumud Kalia, received stock options and restricted stock units as part of a compensation package.

Guardant Health's Chief Commercial Officer, Chris Freeman, received stock options and restricted stock units as part of his compensation package.

Craig Eagle, Chief Medical Officer of Guardant Health, was granted stock options and restricted stock units on November 8, 2024, as part of his compensation.

Darya Chudova, Chief Technology Officer of Guardant Health, was granted stock options and restricted stock units on November 8, 2024, as part of her compensation.

Guardant Health's Chief Financial Officer, Michael Bell, received stock options and restricted stock units on November 8, 2024, as part of his compensation.

Director Roberto Mignone of Guardant Health, Inc. acquired stock options and restricted stock units on November 8, 2024, as part of a compensation package.

Director Meghan Joyce reports the vesting and subsequent disposition of restricted stock units in Guardant Health, Inc.

Darya Chudova, Chief Technology Officer of Guardant Health, reports the acquisition and disposal of common stock related to the vesting of restricted stock units.

Director Steve Krognes reports a transaction involving Guardant Health, Inc. common stock related to the vesting of restricted stock units.

Director Tariq Musa reports the acquisition and disposal of Guardant Health, Inc. common stock and restricted stock units on October 15, 2024.

Director Myrtle S. Potter reports the vesting and subsequent ownership of Guardant Health common stock.

Director Meghan V. Joyce filed a Form 4 disclosing the acquisition of 66 shares of Guardant Health, Inc. common stock on October 4, 2024, through the vesting of restricted stock units.

John G. Saia, Chief Legal Officer of Guardant Health, reports the acquisition and disposal of common stock and restricted stock units to meet tax obligations.

Kumud Kalia, Chief Information Officer of Guardant Health, reports the vesting and subsequent tax withholding of restricted stock units.

Chris Freeman, Chief Commercial Officer of Guardant Health, reports the vesting and subsequent tax withholding of restricted stock units.

Craig Eagle, Chief Medical Officer of Guardant Health, reports the vesting and disposal of restricted stock units to cover tax obligations.

Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting and subsequent tax withholding of restricted stock units.

Michael Bell, CFO of Guardant Health, reports the vesting of restricted stock units and subsequent stock transactions to cover tax obligations.

AmirAli Talasaz, Co-CEO of Guardant Health, reports the acquisition and disposal of common stock related to the vesting of restricted stock units.

Director Steve Krognes reported a transaction involving Guardant Health, Inc. stock on September 30, 2024.

Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, reported the vesting of restricted stock units and associated tax withholding, resulting in changes to his beneficial ownership of company stock.

Director Tariq Musa reports the acquisition and disposal of Guardant Health, Inc. stock and restricted stock units.

John G. Saia, Chief Legal Officer of Guardant Health, Inc., exercised stock options and disposed of shares to cover tax withholding obligations.

Director Myrtle S. Potter reports the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.

Chief Information Officer of Guardant Health, Kumud Kalia, reports the vesting of restricted stock units and associated tax withholding.

Chris Freeman, Chief Commercial Officer of Guardant Health, reports the vesting of restricted stock units and associated tax withholding.

Chief Medical Officer of Guardant Health, Craig Eagle, reports the vesting of restricted stock units and associated tax withholding.

Michael Bell, CFO of Guardant Health, reports the vesting and subsequent tax withholding of restricted stock units.

John G. Saia, Chief Legal Officer of Guardant Health, Inc., reports a transaction involving common stock to cover tax withholding obligations.

Kumud Kalia, Chief Information Officer of Guardant Health, reports the vesting of restricted stock units and subsequent stock transactions to cover tax obligations.